(DIAGNOSTIC IMAGING) -- FDA Plans to Improve Review Path for Medical Devices
By Sara Michael
The FDA this week outlined a plan to improve the path to market for medical devices, including streamlining the review for low-risk devices and clarifying when clinical data should be submitted.
The 25 actions will result in “a smarter medical device program that supports innovation, keeps jobs here at home, and brings important, safe, and effective technologies to patients quickly,” Jeffrey Shuren, MD, JD, director of FDA’s Center for Devices and Radiological Health (CDRH), said in a statement.
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC